SARS-CoV-2 Spike receptor binding domain, RBD (348-357)

Product Name: SARS-CoV-2 Spike receptor binding domain, RBD (348-357)

Sequence One Letter Code: ASVYAWNRKR

Sequence Three Letter Code: H-Ala-Ser-Val-Tyr-Ala-Trp-Asn-Arg-Lys-Arg-OH

Molecular Weight: 1250.5

Purity: ≥ 95% 

Storage Conditions: - 20 °C

Source / Species: SARS-CoV-2

Conjugation: Unconjugated

Code Nacres: NA.26

Application: SARS-CoV-2 Spike RBD (348–357) is a synthetic peptide representing residues 348–357 of the spike receptor-binding domain, based on RefSeq YP_009724390.1. The RBD is central to ACE2 receptor binding, viral attachment, and infectivity. This short peptide sequence is useful for targeted studies of spike protein structure, antibody recognition, and epitope profiling. SARS-CoV-2 Spike RBD (348–357) supports research in viral entry biology, immune response characterization, peptide-based diagnostic development, and therapeutic investigations focused on SARS-CoV-2 spike protein interactions and receptor-binding domain functionality.